0001209191-22-003528.txt : 20220118 0001209191-22-003528.hdr.sgml : 20220118 20220118171118 ACCESSION NUMBER: 0001209191-22-003528 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220114 FILED AS OF DATE: 20220118 DATE AS OF CHANGE: 20220118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duke William E. CENTRAL INDEX KEY: 0001636135 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38822 FILM NUMBER: 22535910 MAIL ADDRESS: STREET 1: C/O VALERITAS, INC., 750 ROUTE 202 SOUTH STREET 2: SUITE 600 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kaleido Biosciences, Inc. CENTRAL INDEX KEY: 0001751299 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 617-674-9000 MAIL ADDRESS: STREET 1: 18 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-14 0 0001751299 Kaleido Biosciences, Inc. KLDO 0001636135 Duke William E. C/O KALEIDO BIOSCIENCES,INC 65 HAYDEN AVE LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer Restricted Stock Units 2022-01-14 4 A 0 44990 0.00 A Common Stock 44990 44990 D Restricted Stock Units 2022-01-14 4 A 0 125000 0.00 A Common Stock 125000 125000 D Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units shall vest 100% on April 30, 2022 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer. The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer. /s/ William Duke, Jr. 2022-01-18